Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia (Q35810054)

10 August 2017

1 reference

title

Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia (English)

1 reference

10 August 2017

0 references

1

Bita Moghaddam

1 reference

10 August 2017

19 February 2004

1 reference

10 August 2017

1 reference

10 August 2017

174

1 reference

10 August 2017

1

1 reference

10 August 2017

39-44

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-004-1792-z

10 August 2017

0 references

cites work

Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus.

1 reference

12 December 2020

The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats

1 reference

12 December 2020

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

1 reference

12 December 2020

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

1 reference

12 December 2020

Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones

1 reference

12 December 2020

Prefrontal neurons and the genetics of schizophrenia

1 reference

12 December 2020

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

1 reference

12 December 2020

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

12 December 2020

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

12 December 2020

Schizophrenia and glutamatergic transmission

1 reference

12 December 2020

Direct and indirect modulation of the N-methyl D-aspartate receptor

1 reference

12 December 2020

Genes for schizophrenia? Recent findings and their pathophysiological implications

1 reference

12 December 2020

Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents

1 reference

12 December 2020

Bringing order to the glutamate chaos in schizophrenia

1 reference

12 December 2020

Localization of mGluR6 to dendrites of ON bipolar cells in primate retina

1 reference

12 December 2020

Glutamate stimulates inositol phosphate formation in striatal neurones

1 reference

12 December 2020

A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.

1 reference

12 December 2020

Metabotropic glutamate receptors stimulate phospholipase D via different pathways in the adult and neonate rat hippocampus

1 reference

12 December 2020

Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system

1 reference

12 December 2020

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

1 reference

12 December 2020

Metabotropic glutamate receptors

1 reference

12 December 2020

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

12 December 2020

Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia

1 reference

12 December 2020

Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release

1 reference

12 December 2020

The chemical excitation of spinal neurones by certain acidic amino acids

1 reference

12 December 2020

Regulation of neurotransmitter release by metabotropic glutamate receptors

1 reference

12 December 2020

Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment

1 reference

12 December 2020

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

1 reference

12 December 2020

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.

1 reference

12 December 2020

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients

1 reference

12 December 2020

The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity

1 reference

12 December 2020

Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia

1 reference

12 December 2020

Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine

1 reference

12 December 2020

Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites

1 reference

12 December 2020

The neuropathology of schizophrenia. A critical review of the data and their interpretation

1 reference

12 December 2020

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

1 reference

12 December 2020

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

1 reference

12 December 2020

Localization of metabotropic glutamate receptor type 2 in the human brain

1 reference

12 December 2020

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

1 reference

12 December 2020

Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease

1 reference

12 December 2020

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

12 December 2020

Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

1 reference

12 December 2020

Molecular determinants of metabotropic glutamate receptor signaling.

1 reference

12 December 2020

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

1 reference

12 December 2020

Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site

1 reference

12 December 2020

Cloned glutamate receptors

1 reference

12 December 2020

A new type of glutamate receptor linked to inositol phospholipid metabolism

1 reference

12 December 2020

The functional architecture of the prefrontal cortex and schizophrenia

1 reference

12 December 2020

Ionotropic glutamate receptors as therapeutic targets in schizophrenia

1 reference

12 December 2020

(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus

1 reference

12 December 2020

Pharmacology and functions of metabotropic glutamate receptors

1 reference

12 December 2020

Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia

1 reference

12 December 2020

Glycine modulators in schizophrenia.

1 reference

12 December 2020

LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress

1 reference

12 December 2020

Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function.

1 reference

12 December 2020

10.1007/S00213-004-1792-Z

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15205877